AIA®-CL2400
Powerful and Flexible Immunoassay Testing: The AIA-CL2400 is Tosoh’s highest productivity immunoassay analyzer, ideal for large hospitals and clinics, reference and core labs. Like all other Tosoh AIA-CL automated immunoassay analyzers, utilizes the unique CL-AIA Pack twin cup format. With a throughput of up to 240 results per hour and assay time of 15 minutes for most analytes, this instrument is suited to a high level of wor…
Features:
- Throughput: Up to 240 tests/hour
- Continuous loading with on-board capacity of up to: 200 samples 960 tips 1280 twin cups
- Up to 40 analytes per specimen
- Walk away time ~ 3.5 hours
- Long calibration stabilities (90 days for all assays)
- Reagent Cooling ≤ 15°C
- STAT position
- Automated daily maintenance
Tosoh’s immunoassay range offers a unique solution to labs with advanced automation and improved patient outcomes.
Brochures
Diagnosis made clear through Presepsin testing
This brochure explores the clinical utility of Presepsin (sCD14-ST), a biomarker that rises early during bacterial infection and sepsis. Discover how Presepsin testing can support early diagnosis, ongoing treatment monitoring, and risk stratification, providing clinicians with valuable information alongside other diagnostic tools as part of a comprehensive sepsis management strategy.
The assay is available on AIA®-360 and AIA®-CL300 analyzers from Tosoh Bioscience - Diagnostics EMEA, delivering results in approximately 15–20 minutes for rapid clinical decision-making in emergency and critical care settings. The brochure also outlines the biological role of Presepsin in the innate immune response and its growing evidence base in sepsis diagnosis and prognosis.
Resource details
- Resource type: Product brochure
- Page count: 8
- Read time: 12 mins













